ELVN(Enliven Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 61 | $47.60 |
| 2026-11-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 4,939 | $46.83 |
| 2026-10-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 6,018 | $38.48 |
| 2026-10-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 5,000 | $38.47 |
| 2026-10-01 | Garland J. Scott | 董事 | 公开市场卖出 | 13,000 | $46.67 |
| 2026-09-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 289 | $51.49 |
| 2026-09-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 2,194 | $50.72 |
| 2026-09-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 3,535 | $50.03 |
| 2026-09-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 240 | $51.48 |
| 2026-09-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 1,844 | $50.71 |
| 2026-09-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 2,916 | $50.03 |
| 2026-08-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 1,388 | $59.35 |
| 2026-08-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 4,630 | $58.35 |
| 2026-08-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 1,100 | $59.35 |
| 2026-08-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | 公开市场卖出 | 3,900 | $58.37 |
| 2026-08-04 | Derynck Mika K | 董事 | 公开市场卖出 | 158,795 | $60.21 |
| 2026-07-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 123 | $53.87 |
| 2026-07-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 2,638 | $53.38 |
| 2026-07-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 2,564 | $52.32 |
| 2026-07-17 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 公开市场卖出 | 369 | $51.48 |